Pharmacogenetics and Age-Related Macular Degeneration
Pharmacogenetics seeks to explain interpatient variability in response to medications by investigating genotype-phenotype correlations. There is a small but growing body of data regarding the pharmacogenetics of both nonexudative and exudative age-related macular degeneration. Most reported data con...
Main Authors: | Stephen G. Schwartz, Milam A. Brantley |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2011/252549 |
Similar Items
-
Pharmacogenetics and nutritional supplementation in age-related macular degeneration
by: Hampton BM, et al.
Published: (2015-05-01) -
Research progress of pharmacogenetics with wet age-related macular degeneration
by: Si-Meng Zheng, et al.
Published: (2020-01-01) -
Genetics and age-related macular degeneration: a practical review for the clinician
by: Schwartz SG, et al.
Published: (2016-07-01) -
Metabolome-wide association study of neovascular age-related macular degeneration.
by: Melissa P Osborn, et al.
Published: (2013-01-01) -
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
by: Kitchens JW, et al.
Published: (2013-10-01)